| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.38 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |